<?xml version="1.0" encoding="UTF-8"?>
<p>There are two lessons to be learned from the Thai practice of compulsory license. One is the Thai government’s planning and coordination to overcome various barriers and challenges, including a remarkably orderly implementation of the “government use” system. The Thai MOH established a government committee directing the government agency’s work on compulsory license to ensure that the drugs obtained through the compulsory license are on the national essential list for government use based on Article 51 of Thailand’s Patent Act of 1979, which stated that the government can sue the patent owner’s rights as their own under certain conditions. The committee broadened the special conditions for public use of compulsory license drugs to include the following: 
 <list list-type="bullet">
  <list-item>
   <p>To resolve the public health issues</p>
  </list-item>
  <list-item>
   <p>To be used in emergency situations</p>
  </list-item>
  <list-item>
   <p>To prevent the infection disease outbreaks</p>
  </list-item>
  <list-item>
   <p>To save lives</p>
  </list-item>
 </list>
</p>
